Outputs (645)

Supporting Long Covid Care: a webtool to facilitate help-seeking among people with Long Covid (2024)
Presentation / Conference Contribution
Clutterbuck, D., Smyth, N., Begum, F., Chew-Graham, C., Mcgowan, A., Pantelic, M., Ridge, D., Tran, H., Williams, R., & Alwan, N. A. Supporting Long Covid Care: a webtool to facilitate help-seeking among people with Long Covid. Presented at 17th European Public Health Conference 2024 Sailing the Waves of European Public Health: Exploring a Sea of Innovation Lisbon, Portugal 12–15 November 2024

Background Long Covid (also known as Post-COVID19 Condition or Post-COVID Syndrome) is characterised by persistent symptoms following SARSCoV2 infection not explained by other pathology. Some evidence suggests that people from marginalised communitie... Read More about Supporting Long Covid Care: a webtool to facilitate help-seeking among people with Long Covid.

Family-based sexual health intervention for adolescents; A systematic review and meta-analysis (2024)
Presentation / Conference Contribution
Mataraarachchi, D., Shepherd, T., Ariyadasa, G., Bajpai, R., Corp, N., & Paudyal, P. Family-based sexual health intervention for adolescents; A systematic review and meta-analysis. Presented at 17th European Public Health Conference 2024 Sailing the Waves of European Public Health: Exploring a Sea of Innovation Lisbon, Portugal 12–15 November 2024

Background Family-based interventions are important in promoting adolescent sexual health outcomes. However, the effectiveness of these interventions in promoting adolescent sexual and reproductive health (ASRH) in Lower and middle-income countries (... Read More about Family-based sexual health intervention for adolescents; A systematic review and meta-analysis.

Sex sifferences in lifes essential eight and its association with mortality among adults without known CVD (2024)
Presentation / Conference Contribution
Kobo, O., Kaur, G., Gulati, M., & Mamas, M. Sex sifferences in lifes essential eight and its association with mortality among adults without known CVD. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background The American Heart Association’s Life’s Essential 8 (LE8) score is a helpful tool to quantify cardiovascular health (CVH) metrics. Sex differences in relation to LE8 and its association with mortality are not known. Methods The National He... Read More about Sex sifferences in lifes essential eight and its association with mortality among adults without known CVD.

Sex differences in secondary prevention and outcomes post-myocardial infarction in Scotland (2024)
Presentation / Conference Contribution
Pana, T., Mamas, M. A., Myint, P. K., & Dawson, D. Sex differences in secondary prevention and outcomes post-myocardial infarction in Scotland. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Sex differences in outcomes after myocardial infarction (MI) are of increasing interest. Differential receipt of evidence-based treatments may contribute to such disparities. Purpose In this study, we investigate sex differences in the bur... Read More about Sex differences in secondary prevention and outcomes post-myocardial infarction in Scotland.

Association of lifes essential 8 and mortality among adults with and without CVD (2024)
Presentation / Conference Contribution
Kobo, O., Kaur, G., Gulati, M., & Mamas, M. Association of lifes essential 8 and mortality among adults with and without CVD. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Differences in the American Heart Association’s Life’s Essential 8 (LE8) score and its association with mortality based on the presence of clinically prevalent cardiovascular disease (CVD) has not been assessed previously. Methods Data fro... Read More about Association of lifes essential 8 and mortality among adults with and without CVD.

Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer (2024)
Presentation / Conference Contribution
Dafaalla, M., Costa, F., Jia, H., Wijeysundera, H., Rashid, M., Graham, M., Wojakowski, W., Chieffo, A., Mintz, G., & Mamas, M. Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Treatment of patients with cancer presenting with ST-elevation myocardial infarction (STEMI) is complex given the increased risk of both thrombotic and major bleeding complications. We evaluated the risk of major bleeding and re-infarction... Read More about Ischemic and bleeding risk after ST-segment elevated myocardial infarction in patients with active cancer.

Blood pressure lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of 500 randomised, double-blind placebo-controlled trials (2024)
Presentation / Conference Contribution
Wang, N., Salam, A., Pant, R., Kota, V., Dhurjati, R., Kumar, A., Haghdoost, F., Gnanenthiran, S., Kaistha, P., Prasad, H., Kanukula, R., & Rodgers, A. Blood pressure lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of 500 randomised, double-blind placebo-controlled trials. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Each 1 mmHg reduction in systolic blood pressure (SBP) reduces the risk of major cardiovascular disease events by about 2%. However, there are currently no tools to provide randomised trial-derived estimates of blood pressure (BP)-lowering... Read More about Blood pressure lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of 500 randomised, double-blind placebo-controlled trials.

Mechanical thrombectomy is associated with worse outcomes in infective endocarditis: a retrospective cohort study (2024)
Presentation / Conference Contribution
Barlas, R., Pana, T., Myint, P., & Mamas, M. A. Mechanical thrombectomy is associated with worse outcomes in infective endocarditis: a retrospective cohort study. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Acute Ischaemic stroke (AIS) is a common complication in infective endocarditis (IE) and associated is with high mortality. There is a paucity of data evaluating mechanical thrombectomy (MT) in patients with AIS secondary to IE. Our retros... Read More about Mechanical thrombectomy is associated with worse outcomes in infective endocarditis: a retrospective cohort study.

Ethnic disparity in the care and management of non-ST-segment elevation myocardial infarction and its impact on short-term and long-term survival: a long-term study of a national registry (2024)
Presentation / Conference Contribution
Yera, H., Weight, N., Moledina, S. M., & Mamas, M. A. Ethnic disparity in the care and management of non-ST-segment elevation myocardial infarction and its impact on short-term and long-term survival: a long-term study of a national registry. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background Previous examination of data from the United Kingdom indicates no apparent ethnic disparity in the treatment of patients hospitalised with non-ST-segment elevation myocardial infarction (NSTEMI). However, it remains uncertain whether this... Read More about Ethnic disparity in the care and management of non-ST-segment elevation myocardial infarction and its impact on short-term and long-term survival: a long-term study of a national registry.

Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials (2024)
Presentation / Conference Contribution
Lee, E., Tan, B., Chin, Y. H., Chan, Y. H., Ong, J., Goh, R. S. J., Chong, B., Anand, V. V., Kong, G., Wang, J. W., Muthiah, M. D., Loh, P. H., Chan, M. Y., Chew, N. W. S., & Mamas, M. A. Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials. Presented at ESC Congress 2024 30 August – 02 September London, UK Abstract Supplement

Background and Purpose Major adverse cardiovascular event (MACE) is one of the most used composite outcomes in coronary artery disease (CAD) trials, though its lack of a standardised definition has led to ambiguity and challenges in its interpretatio... Read More about Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials.